REGISTER now: Visser ai webinar - BEYOND THE HYPE: AI IN PATENT PROSECUTION
​

'Gene Patents in Europe Relatively Stable Despite Uncertainty in the US', by Andrew Sharples

No items found.
​
25 March 2011
Tags
Life
Table of contents
  • Toc Heading
  • Toc Heading

Partner and head of EIP Life, Andrew Sharples, has had an article published on the website of a US biotech magazine, Genetic Engineering and Biotechnology News (GEN).

The article entitled Gene Patents in Europe Relatively Stable Despite Uncertainty in the US, discusses the future of gene patents in Europe contrasting the European position with the US Myriad case.

To read the article in full, click here.

Related articles

See all articles

EIP ranked Band 1 in Chambers UK 2027, with three lawyers also recognised
14 October 2026
Chambers recognised EIP for its patent litigation work and its strength in disputes concerning FRAND licensing and standard essential patents.
​
EIP named a leading patent firm again in the Legal 500 UK 2027
01 October 2026
EIP has retained its Tier 1 ranking in PATMA: Patents and its Tier 2 ranking in IP: Patents (contentious and non-contentious) in the Legal 500 UK 2027 guide. In addition, Gary Moss was inducted into the Hall of Fame in IP: Patents.
​
Five EIP partners named among the world's leading IP strategists in the 2026 IAM Strategy 300
17 August 2026
Christof Höhne, Darren Smyth, Heather McCann, James Seymour, and Sebastian Fuchs have all been named in this year's list, each recognised for their own approach to building patent value for clients.
​